BIOPHARMA DIVE

biopharma-dive-logo

BioPharma Dive provides journalism and insight into news and trends of biotech and pharma.

#SimilarOrganizations #People #Website #More

BIOPHARMA DIVE

Social Links:

Industry:
Biotechnology Media And Entertainment News Pharmaceutical

Address:
Washington, District Of Columbia, United States

Country:
United States

Website Url:
http://www.biopharmadive.com

Total Employee:
51+

Status:
Active

Contact:
202.331.2480

Email Addresses:
[email protected]


Similar Organizations

asia-pacific-biotech-news-logo

Asia Pacific Biotech News

Asia Pacific Biotech News provides reporting for research and industrial developments in the field of science and technology.

fiercemedicaldevices-logo

FierceMedicalDevices

FierceMedicalDevices provides breaking news and critical insights into the medical device and diagnostics industries.

pharm-exec-logo

Pharm Exec

Pharm Exec provides its audience of pharmaceutical and biopharmaceutical executives with the analysis of business, strategy.

Current Employees Featured

not_available_image

Ned Pagliarulo
Ned Pagliarulo Lead Editor @ BioPharma Dive
Lead Editor
2020-01-01

Official Site Inspections

http://www.biopharmadive.com Semrush global rank: 686.28 K Semrush visits lastest month: 61.76 K

  • Host name: 172.64.145.224
  • IP address: 172.64.145.224
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BioPharma Dive"

About Us - BioPharma Dive

BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma. The newsletter and website cover topics ranging from clinical readouts to FDA approvals, gene therapy to drug …See details»

Biotech and Pharma Industry News | BioPharma Dive

BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA …See details»

BIO to restructure, lay off staff in shakeup of lobbying …

May 20, 2024 The Biotechnology Innovation Organization is restructuring after conducting a “thorough evaluation” of its operations and priorities, in a move that will see 30 employees depart the lobbying group, known as BIO for short. …See details»

BioPharma Dive - Crunchbase Company Profile

BioPharma Dive provides journalism and insight into news and trends of biotech and pharma.See details»

BioPharma Dive - LinkedIn

BioPharma Dive | 15,436 followers on LinkedIn. We provide business journalism and in-depth insight into the most impactful news and trends shaping biotech and pharma | BioPharma Dive provides in ...See details»

Editorial Team | BioPharma Dive

Our editorial team provides in-depth journalism and insight into the most impactful news and trends shaping the industries we cover. We invite you to send us a message if you're looking to …See details»

BioPharma Dive (Past Media Partner) - Future Pharma 2025

BioPharma Dive is the mobile friendly industry dashboard for biotech and pharma executives. We curate the industry's most important news,social commentary, stock updates, industry jobs, …See details»

July 26 - Why 'flat is the new up' for startups, the next gene …

About BioPharma Dive. BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma.See details»

About Us | BioPharma Dive

About BioPharma Dive . BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma.See details»

Tive & BioPharma Dive Reveal How Pharma Leaders …

Jan 21, 2025 Survey Reveals 51% of Pharma Leaders Anticipate Significant Risk Increase, While 49% Cite Shipment Condition Visibility as Top ChallengeBOSTON, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Tive, the global ...See details»

‘It’s not for the faint of heart.’ How 3 CEOs …

Feb 14, 2025 Finer, along with the CEOs of two other drugmakers that went public last year, shared their experiences and offered advice earlier this week, during a panel hosted by …See details»

BioPharma Dive - Facebook

BioPharma Dive. 14,476 likes · 50 talking about this. Providing in-depth journalism and insight into the news and trends impacting the biopharma spaceSee details»

Want better cancer treatments? Make biopharma more like Silicon …

In an interview with PharmaVoice, Alicia Zhou, the new head of the nonprofit Cancer Research Institute, expressed a desire to foster deeper partnerships between scientists and the …See details»

BioPharma Dive (BioPharma Dive) - 药物管线_专利_临床试验_投融 …

Roche has a big problem. With competition threatening some of its older and most lucrative biologic drugs, the Swiss pharmaceutical giant expects that, in three years time, sales from …See details»

Nkarta to lay off staff, senior leadership, in bid to advance ...

Mar 27, 2025 The cuts will impact 53 positions, freeze some future hires and enable it to operate into 2029. In a statement, CEO Paul Hastings said the restructuring prioritizes “investment in …See details»

BioPharma Dive (@BioPharmaDive) on Flipboard

BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma. The newsletter and website cover topics ranging from clinical …See details»

Simplification for success: Rewiring the biopharma operating model

Mar 21, 2025 Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»

Whitepapers, webinars, and videos | BioPharma Dive

Whitepapers, webinars, videos, PDF downloads and other resources about the biotech and biopharmaceutical industrySee details»

‘The bar has risen’: China’s biotech gains push US companies to …

Jan 16, 2025 Fast-moving research. Today’s deal boom has roots in efforts by the Chinese government to upgrade the country’s biotech capabilities by upping investment in …See details»

Protagonist says Takeda-partnered drug succeeds in rare blood …

Mar 3, 2025 Dive Insight: The positive results for rusfertide are the second Phase 3 success for a drug developed by Protagonist, which in November reported a psoriasis pill it’s developing …See details»

linkstock.net © 2022. All rights reserved